K-numberK252979
Device nameVoyager DSLT (430840610)
ApplicantBelkin Vision, Ltd.
Product codeHQF
Device classClass II
Decision dateApr 7, 2026
DecisionSubstantially Equivalent
Regulation886.4390
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Voyager DSLT is a Q-switched, 532 nm Nd:YAG laser designed for selective laser trabeculoplasty (SLT), a procedure to treat glaucoma. It delivers 120 laser spots in a predefined elliptical pattern to the trabecular meshwork through the limbus without requiring a contact lens, using automated targeting with eye-tracking compensation for patient movement.

Technological characteristics

The Voyager DSLT is identical to its predicate device (BELKIN Eagle) in laser type, wavelength (532 nm), pulse duration (3 ns), pulse energy range (1.1–1.9 mJ), repetition rate (50 Hz), spot diameter (400 µm), aiming laser (635 nm diode), delivery method (automated non-contact pattern delivery), and physical dimensions. Software was updated with three features: completion of interrupted treatments, target definition screen modifications, and automated test card results export—none raising new safety or effectiveness questions.

Test standards cited

IEC 62304:2015 Medical Device Software - Software Life Cycle Processes; FDA 'Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices' (major level of concern); FDA 'Applying Human Factors and Usability Engineering to Medical Devices' guidance.

Substantial equivalence argument

The Voyager DSLT has identical indications for use, laser parameters, target tissue, delivery method, and auxiliary optical characteristics as the predicate Eagle device. The three software changes do not introduce new safety or effectiveness questions and are supported by bench testing, human factors analysis, and validation testing. Non-clinical testing demonstrates the device functions as intended and is substantially equivalent to the predicate device.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →